Inventor
FERRANDI MARA
IT13 patents
⚠️ This page may combine multiple inventors who share the name “FERRANDI MARA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGMA TAU IND FARMACEUTI
6 patentsUS5721227AFeb 24, 1998
17-aryl and 17-heterocyclyl-14β-5α-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
SIGMA TAU IND FARMACEUTI46 citations91
US5324719AJun 28, 1994
Therapeutical method for the treatment of hypertension
SIGMA TAU IND FARMACEUTI4 citations59
US5556846ASep 17, 1996
17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, and pharmaceutical compositions containing same
SIGMA TAU IND FARMACEUTI0 citations51
US5489582AFeb 6, 1996
14-deoxy-14α-cardenolides 3β-thioderivatives and pharmaceutical composition comprising same for treating cardiovascular disorders
SIGMA TAU IND FARMACEUTI0 citations51
US8822692B2Sep 2, 2014
Diterpenoid derivatives endowed of biological properties
SIGMA TAU IND FARMACEUTI0 citations40
US8022203B2Sep 20, 2011
Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes
SIGMA TAU IND FARMACEUTI0 citations31
WINDTREE THERAPEUTICS INC
3 patentsUS12343350B2Jul 1, 2025
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
WINDTREE THERAPEUTICS INC0 citations57
US11583540B2Feb 21, 2023
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
WINDTREE THERAPEUTICS INC0 citations57
US11197869B2Dec 14, 2021
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
WINDTREE THERAPEUTICS INC0 citations57